Methicillin-resistant Staphylococcus aureus in diabetic foot infections

Related Experiment Video

Updated: Jun 8, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Ioanna Eleftheriadou1, Nicholas Tentolouris, Vasiliki Argiana

  • 1Department of Propaedeutic and Internal Medicine, Athens University Medical School, Greece.

Drugs
|September 15, 2010
PubMed

Insights

Diabetic foot ulcers frequently develop infections, with methicillin-resistant Staphylococcus aureus (MRSA) posing a growing threat. MRSA infections increase the need for amputation and surgical intervention, necessitating careful treatment strategies.

Area of Science:

  • Infectious Diseases
  • Diabetology
  • Antimicrobial Resistance

Background:

  • Diabetic foot ulcers are commonly complicated by bacterial infections.
  • Staphylococcus aureus is a predominant pathogen, with methicillin-resistant S. aureus (MRSA) accounting for 15-30% of infections.
  • Increasing prevalence of MRSA, including vancomycin-resistant strains, is a global concern.

Purpose of the Study:

  • To review the epidemiology and clinical implications of MRSA in diabetic foot ulcers.
  • To outline current treatment strategies for MRSA infections in this patient population.
  • To highlight emerging antimicrobial agents for MRSA treatment.

Main Methods:

  • Literature review of studies on diabetic foot ulcer infections.
  • Analysis of prevalence data for MRSA.
  • Summary of clinical outcomes and treatment guidelines for MRSA infections.

Main Results:

  • MRSA prevalence in infected diabetic foot ulcers ranges from 15-30% and is increasing.
  • Risk factors for MRSA isolation include osteomyelitis, nasal carriage, prior antibiotic use, and larger/longer-duration ulcers.
  • MRSA infections are associated with increased rates of amputation and surgical debridement.

Conclusions:

  • MRSA is a significant pathogen in diabetic foot ulcers, associated with poorer outcomes.
  • Treatment selection depends on infection severity and local resistance patterns, with specific antibiotics recommended for mild/moderate and severe infections.
  • Newer agents show promise but require further data for definitive use in diabetic foot infections.

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...